Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesus Fernandez-Gomez

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
BJU International|May 20, 2011
Peripheral neuropathy: an underdiagnosed cause of erectile dysfunctionConsuelo Valles-Antuña, Jesus Fernandez-Gomez, Fernando Fernandez-Gonzalez
BJU International|August 18, 2009
Sympathetic skin response in patients with erectile dysfunctionConsuelo Valles-Antuña, Jesus Fernandez-Gomez, Safwan Escaf, et al.
Scandinavian Journal of Urology and Nephrology|January 20, 2011
Relationship between metalloprotease expression in tumour and stromal cells and aggressive behaviour in prostate carcinoma: Simultaneous high-throughput study of multiple metalloproteases and their inhibitors using tissue array analysis of radical prostatectomy samplesJesus Fernandez-Gomez, Safwan Escaf, Luis-Ovidio Gonzalez, et al.
European Urology|June 21, 2005
Telomere length on bladder washing samples from patients with bladder cancer correlates with tumor characteristics flow cytometry method for quantitative fluorescence in situ hybridization (flow-FISH technique)Jesus Fernandez-Gomez, Safwan Escaf Barmadah, David Gosalbez, et al.
Journal of Cancer Research and Clinical Oncology|October 28, 2016
Stromal factors involved in human prostate cancer development, progression and castration resistanceNoemi Eiro, Jesus Fernandez-Gomez, Raquel Sacristán, et al.
European Urology|January 9, 2007
Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancerJesus Fernandez-Gomez, Juan J Rodríguez-Martínez, Safwan Escaf Barmadah, et al.
European Urology|May 31, 2011
The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: external validation of the EORTC risk tablesJesus Fernandez-Gomez, Rosario Madero, Eduardo Solsona, et al.
European Urology|October 24, 2007
Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trialsJesus Fernandez-Gomez, Eduardo Solsona, Miguel Unda, et al.
The Journal of Urology|September 18, 2009
Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring modelJesus Fernandez-Gomez, Rosario Madero, Eduardo Solsona, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
BJU International|May 20, 2011
Peripheral neuropathy: an underdiagnosed cause of erectile dysfunctionConsuelo Valles-Antuña, Jesus Fernandez-Gomez, Fernando Fernandez-Gonzalez
BJU International|August 18, 2009
Sympathetic skin response in patients with erectile dysfunctionConsuelo Valles-Antuña, Jesus Fernandez-Gomez, Safwan Escaf, et al.
Scandinavian Journal of Urology and Nephrology|January 20, 2011
Relationship between metalloprotease expression in tumour and stromal cells and aggressive behaviour in prostate carcinoma: Simultaneous high-throughput study of multiple metalloproteases and their inhibitors using tissue array analysis of radical prostatectomy samplesJesus Fernandez-Gomez, Safwan Escaf, Luis-Ovidio Gonzalez, et al.
European Urology|June 21, 2005
Telomere length on bladder washing samples from patients with bladder cancer correlates with tumor characteristics flow cytometry method for quantitative fluorescence in situ hybridization (flow-FISH technique)Jesus Fernandez-Gomez, Safwan Escaf Barmadah, David Gosalbez, et al.
Journal of Cancer Research and Clinical Oncology|October 28, 2016
Stromal factors involved in human prostate cancer development, progression and castration resistanceNoemi Eiro, Jesus Fernandez-Gomez, Raquel Sacristán, et al.
European Urology|January 9, 2007
Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancerJesus Fernandez-Gomez, Juan J Rodríguez-Martínez, Safwan Escaf Barmadah, et al.
European Urology|May 31, 2011
The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: external validation of the EORTC risk tablesJesus Fernandez-Gomez, Rosario Madero, Eduardo Solsona, et al.
European Urology|October 24, 2007
Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trialsJesus Fernandez-Gomez, Eduardo Solsona, Miguel Unda, et al.
The Journal of Urology|September 18, 2009
Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring modelJesus Fernandez-Gomez, Rosario Madero, Eduardo Solsona, et al.
Pageof 1